DOST Nods to WMSU Study of PH Herbal Medicines with Inhibitory Properties in Relation to COVID-19 – Manila Bulletin
The Department of Science and Technology (DOST) has funded a study that will look at herbal medicines from the Philippines, which have inhibitory properties against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which causes the disease coronavirus (COVID-19).
In a Facebook post, DOST-IX announced that the agency had given the green light to the team of Dr. Genelyn G. Madjos, associate professor in the College of Science and Mathematics (CSM) at Western Mindanao State University (WMSU). ) to Zamboanga City to conduct the six-month research.
He said funding for research on “Philippine herbal medicines and its components in SARS-CoV-2 mitigation” stands at P126,688.75.
“The study aims to synthesize and compile Philippine herbal medicines with inhibitory properties against SARS-COV-2 and other viruses, and provide the framework for proactive investments in vaccine or drug-based research. derivatives of Philippine herbal medicines to treat COVID-19 within the course of six months,” he said.
“The grant will be used to obtain the necessary supplies, supplies and equipment to conduct a systematic review,” he added.
The Philippine DOST Council for Health Research and Development (PCHRD) provided the grant through the Zamboanga Consortium for Health Research and Development – Regional Research Fund (ZCHRD-RRF).
“DOST, through its various R&D councils, funds studies in the design, implementation and management of research projects,” DOST-IX said.
He encouraged regular staff and faculty members of research institutes, medical and allied health sciences, hospitals and other health-related organizations to submit research proposals to the ZCHRD Secretariat through email. .
To find out more about ZCHRD-RRF, interested parties were asked to call (062) 991-1024 or text 0995-1548-865 and search for Marielle Atilano, or email DOST -IX to [email protected] or visit its Facebook page at www.facebook.com/DOSTRegion9.
SUBSCRIBE TO THE DAILY NEWSLETTER
CLICK HERE TO JOIN